Joan Walker to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Joan Walker has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.061
-
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study. Gynecol Oncol. 2021 05; 161(2):512-515.
Score: 0.047
-
Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkers. Cancer. 2003 Nov 01; 98(9 Suppl):2044-51.
Score: 0.014